ArticleOncotarget2016

A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.

Mi Jeong Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.